Exploratory Study to Standard Triple Therapy With Tegoprazan(by Dose) in H. Pylori Positive Patients

Clinical trial NCT05933031 · UNKNOWN

Trial details

NCT number: NCT05933031
Sponsor: HK inno.N Corporation
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Helicobacter Pylori Infection

Start date: 2023-02-27
Primary completion: 2024-12-31
Enrollment: 381

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.